Galectin Therapeutics (GALT) Long-Term Investments (2014)
Galectin Therapeutics (GALT) recorded quarterly Long-Term Investments of $10000.0 in Q3 2014, down 84.13% quarter-over-quarter from $63000.0 in Q2 2014.
Galectin Therapeutics (GALT) Long-Term Investments (2014) Analysis & Trends
Galectin Therapeutics' Long-Term Investments history runs 1 years deep, the most recent figure standing at $10000.0 for Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Galectin Therapeutics | 185.83 Mn | 171.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 10,000.00 |
| Jun 30, 2014 | 63,000.00 |
| Mar 31, 2014 | 130,000.00 |